A randomized, single-blind, single-dose study to assess the pharmacokinetic equivalence of the biosimilar ABP 215 and bevacizumab in healthy Japanese male subjects

PURPOSE: Analytic, pharmacokinetic (PK), and clinical similarity between the biosimilar ABP 215 and bevacizumab has previously been demonstrated in global studies. Here we present a phase 1 study in healthy adult Japanese men. METHODS: This study was a randomized, single-blind, single-dose, parallel...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanes, Vladimir, Chow, Vincent, Pan, Zhiying, Markus, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Clinical Trial Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182752/
https://www.ncbi.nlm.nih.gov/pubmed/30269275
http://dx.doi.org/10.1007/s00280-018-3695-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182752/
https://www.ncbi.nlm.nih.gov/pubmed/30269275
http://dx.doi.org/10.1007/s00280-018-3695-4

Ejemplares similares